DCVMN is proud to have been a part of the joint statement at WHA77, highlighting the critical role of collaboration among vaccine manufacturers and global health organizations. Our collective commitment to a pandemic agreement aims to strengthen the innovation ecosystem and encourage companies to take proactive steps in preparing for the next pandemic.
Together, we can enhance global health and ensure a rapid, effective response to future health crises.
Read the statement: https://www.ifpma.org/news/wha77-constituency-statement-on-inb/
